Sign in →

Test Code LAB8603 Mismatch Repair (MMR) Protein Immunohistochemistry Only, Tumor

Additional Codes

IHC

Useful For

Evaluating tumor tissue to identify patients at risk for having hereditary nonpolyposis colon cancer/Lynch syndrome

Additional Tests

Test ID Reporting Name Available Separately Always Performed
MLH1I MLH-1, Immunostain No, (Bill only) Yes
MSH2I MSH-2, Immunostain No, (Bill only) Yes
MSH6I MSH-6, Immunostain No, (Bill only) Yes
PMS2I PMS-2, Immunostain No, (Bill only) Yes

Testing Algorithm

When this test is ordered, MLH1, MSH2, MSH6, and PMS2 stains will always be performed at an additional charge.

 

For more information see Lynch Syndrome Testing Algorithm.

Method Name

Immunohistochemistry (IHC)

Specimen Type

Varies


Necessary Information


Pathology report (final or preliminary) at minimum containing the following information must accompany specimen for testing to be performed:

1. Patient name

2. Block number-must be on all blocks, slides, and paperwork (can be handwritten on the paperwork)

3. Tissue collection date

4. Source of the tissue



Specimen Required


Tumor tissue is required.

 

Preferred:

Specimen Type: Tissue block

Collection Instructions: Submit formalin-fixed, paraffin-embedded tissue block.

 

Acceptable:

Specimen Type: Tissue slide

Slides: 1 Hematoxylin and eosin stained and 10 unstained

Collection Instructions: Submit 1 slide stained with hematoxylin and eosin and 10 unstained, nonbaked slides (5-micron-thick sections) of tumor tissue.


Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Ambient (preferred)
  Refrigerated 

Reject Due To

Specimens that have been decalcified (all methods)
Specimens that have not been formalin-fixed, paraffin-embedded
Bone marrow in EDTA
Reject

Reference Values

An interpretive report will be provided.

Interpretation

The interpretation of molecular biomarker analysis includes an overview of the results and the associated diagnostic, prognostic, and therapeutic implications.

Method Description

Immunohistochemistry staining is used to determine the presence or absence of protein expression for MLH1, MSH2, MSH6, and PMS2. Lymphocytes and normal epithelium exhibit strong nuclear staining and serve as positive internal controls for staining of these proteins.(Cunningham JM, Kim CY, Christensen ER, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 2001;69[4]:780-790; Gill S, Lindor NM, Burgart LJ, et al. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res. 2005;11[18]:6466-6471)

Day(s) Performed

Varies

Report Available

5 to 8 days

Specimen Retention Time

FFPE tissue: Unused portions of FPPE blocks will be returned. Unused, unstained slides: 5 years; Stained slides: Indefinitely.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

88341 MLH1, MLH2, or MLH6 (if appropriate)

88342 PMS2 (if appropriate)

LOINC Code Information

Test ID Test Order Name Order LOINC Value
IHC MMR Protein, IHC Only, Tumor In Process

 

Result ID Test Result Name Result LOINC Value
53258 Result Summary 50397-9
53259 Result In Process
54443 Interpretation 59465-5
53260 Specimen 31208-2
53261 Source 31208-2
54444 Tissue ID 80398-1
53262 MLH1 IHC 81691-8
53263 MSH2 IHC 81692-6
53264 MSH6 IHC 81693-4
53265 PMS2 IHC 81694-2
53266 Released By 18771-6

Forms

1. Molecular Genetics: Inherited Cancer Syndromes Patient Information (T519)

2. If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Secondary ID

35466